يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Ferraccioli, Gianfranco"', وقت الاستعلام: 0.67s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability

    المؤلفون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, SEBASTIANI, Marco, Ramonda, Roberta, Lapadula, Giovanni

    المساهمون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    مصطلحات موضوعية: Drug survival, GISEA, HAQ, LORHEN, Activities of Daily Living, Adalimumab, Adult, Aged, Antirheumatic Agent, Arthriti, Rheumatoid, Biological Product, Disease Progression, Female, Human, Male, Middle Aged, Registrie, Remission Induction, Treatment Outcome, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000386362000003; volume:35; issue:11; firstpage:2649; lastpage:2656; numberofpages:8; journal:CLINICAL RHEUMATOLOGY; https://hdl.handle.net/11381/2977650Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978828157; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-016-3349-zTest
    https://hdl.handle.net/11381/2977650Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability

    المؤلفون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    المساهمون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    مصطلحات موضوعية: Drug survival, GISEA, HAQ, LORHEN, Activities of Daily Living, Adalimumab, Adult, Aged, Antirheumatic Agent, Arthritis, Rheumatoid, Biological Product, Disease Progression, Female, Human, Male, Middle Aged, Registrie, Remission Induction, Treatment Outcome, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27418051; info:eu-repo/semantics/altIdentifier/wos/WOS:000386362000003; volume:35; issue:11; firstpage:2649; lastpage:2656; numberofpages:8; journal:CLINICAL RHEUMATOLOGY; http://hdl.handle.net/11577/3277137Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978828157; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-016-3349-zTest
    http://hdl.handle.net/11577/3277137Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability

    المؤلفون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Ramonda, Roberta, Lapadula, Giovanni, Bergossi, Francesca, SEBASTIANI, Marco

    المساهمون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    مصطلحات موضوعية: Drug survival, GISEA, HAQ, LORHEN, Activities of Daily Living, Adalimumab, Adult, Aged, Antirheumatic Agent, Arthritis, Rheumatoid, Biological Product, Disease Progression, Female, Human, Male, Middle Aged, Registrie, Remission Induction, Treatment Outcome, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27418051; info:eu-repo/semantics/altIdentifier/wos/WOS:000386362000003; volume:35; issue:11; firstpage:2649; lastpage:2656; journal:CLINICAL RHEUMATOLOGY; http://hdl.handle.net/11380/1138105Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978828157; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-016-3349-zTest
    http://hdl.handle.net/11380/1138105Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10Â years in the real-world settings: high rate remission together with normal function ability

    المؤلفون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    المساهمون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    مصطلحات موضوعية: Drug survival, GISEA, HAQ, LORHEN, Activities of Daily Living, Adalimumab, Adult, Aged, Antirheumatic Agent, Arthritis, Rheumatoid, Biological Product, Disease Progression, Female, Human, Male, Middle Aged, Registrie, Remission Induction, Treatment Outcome, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27418051; info:eu-repo/semantics/altIdentifier/wos/WOS:000386362000003; volume:35; issue:11; firstpage:2649; lastpage:2656; numberofpages:8; journal:CLINICAL RHEUMATOLOGY; http://hdl.handle.net/11570/3125483Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978828157; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-016-3349-zTest
    http://hdl.handle.net/11570/3125483Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث